BioPharma Credit PLC (LON:BPCR)
London · Delayed Price · Currency is GBP · Price in USD 0.8720
+0.0040 (0.46%)
Aug 5, 2025, 4:35 PM BST
BioPharma Credit Revenue
In the year 2024, BioPharma Credit had annual revenue of $150.03M USD with 10.53% growth. BioPharma Credit had revenue of $70.89M in the half year ending December 31, 2024, a decrease of -50.16%.
Revenue
$150.03M
Revenue Growth
+10.53%
P/S Ratio
6.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
740.37M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 150.03M | 14.29M | 10.53% |
| Dec 31, 2023 | 135.74M | -82.43M | -37.78% |
| Dec 31, 2022 | 218.17M | 114.29M | 110.02% |
| Dec 31, 2021 | 103.88M | -6.14M | -5.58% |
| Dec 31, 2020 | 110.02M | -40.89M | -27.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HSBC Holdings | 41.03B |
| Barclays | 25.65B |
| London Stock Exchange Group | 9.14B |
| Lloyds Banking Group | 17.67B |
| NatWest Group | 14.86B |
| 3i Group | 5.15B |
| Standard Chartered | 14.69B |
| Prudential | 9.79B |